MM
Mariraj Mariappan
About Mariraj Mariappan
Data last updated:
Mariraj Mariappan is a Director at Marche Healthcare Private Limited (since 2020) and Director at Mahakaruna Foundation For Medical And Research (since 2022). The companies operate in Healthcare and Non-Profit Organizations. The largest current company by reported revenue is Marche Healthcare Private Limited at ₹17.2 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Aug 2020 | 2020 | ₹17.2 Lakh (FY 2024) | Active | |
| Director | 21 Oct 2022 | 2022 | Active |
Board colleagues of Mariraj Mariappan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Muthukumar Mariappan | 06404582 | Marche Healthcare Private Limited | Director |
| Nagappan Gauthama Prabhu | 08878101 | Mahakaruna Foundation For Medical And Research | Director |
| Vajjiravelu | 09773410 | Mahakaruna Foundation For Medical And Research | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mariraj Mariappan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mariraj Mariappan
Mariraj Mariappan currently holds 2 directorships: Marche Healthcare Private Limited (Director, since 29 Aug 2020, revenue ₹17.2 Lakh (FY 2024)); Mahakaruna Foundation For Medical And Research (Director, since 21 Oct 2022).
Mariraj Mariappan was first appointed on 29 Aug 2020 as Director at Marche Healthcare Private Limited. The most recent appointment on record is 21 Oct 2022 at Mahakaruna Foundation For Medical And Research.
The current boards of Mariraj Mariappan's companies include Muthukumar Mariappan (Marche Healthcare Private Limited), Nagappan Gauthama Prabhu (Mahakaruna Foundation For Medical And Research), Vajjiravelu (Mahakaruna Foundation For Medical And Research).